Literature DB >> 7069091

Age does not alter acetaminophen absorption.

M Divoll, B Ameer, D R Abernethy, D J Greenblatt.   

Abstract

Twenty-eight healthy volunteers (age range, 22-78 years) received 650 mg of acetaminophen (AAP) on three separate occasions. The modes of administration were 1) intravenous, 5-minute infusion; 2) oral, with two 325-mg tablets; and 3) oral, with 650 mg as an elixir preparation. Plasma levels of AAP were determined in blood samples drawn up to 12 hours after the dose. The mean (+/- sd) kinetic variables for absorption of AAP from tablets in young and elderly were peak plasma concentration, 11.8 (+/- 4.2) vs 10.9 (+/- 4.1) micrograms/ml; peak time, 0.79 (+/- .54) vs 0.69 (+/- .40) hours after the dose; absorption half-life, 12.6 (+/- 9.8) vs. 8.2 (+/- 5.3) minutes; and absolute systemic availability, 79 (+/- 9) vs 72 (+/- 11) per cent. For AAP elixir, the corresponding values were 12.6 (+/- 5.4) vs 13.7 (+/- 6.0) micrograms/ml; 0.52 (+/- .24) vs 0.54 (+/- .51) hours; 8.6 (+/- 6.2) vs 6.1 (+/- 6.6) minutes; and 87 (+/- 9) vs 80 (+/- 9) per cent. Absolute bioavailability of both oral dosage forms was significantly less then 100 per cent in all groups. Elderly subjects tended to show lower availability of both oral preparations, but the difference was of borderline significance (P less than .50). Age did not influence any other measures of absorption. Since the absorption rate of acetaminophen may be indicative of the gastric emptying rate, age does not appear to alter this rate-limiting step in drug absorption.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069091     DOI: 10.1111/j.1532-5415.1982.tb07093.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  18 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 3.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

4.  Issues in geriatric drug therapy.

Authors:  D Robertson; D H Danforth
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

Review 5.  Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.

Authors:  Christine K O'Neil; Joseph T Hanlon; Zachary A Marcum
Journal:  Am J Geriatr Pharmacother       Date:  2012-10-02

6.  Gastric emptying following brain injury: effects of choice of sedation and intracranial pressure.

Authors:  C J McArthur; T Gin; I M McLaren; J A Critchley; T E Oh
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 7.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 8.  Treatment of chronic non-malignant pain in the elderly: safety considerations.

Authors:  Jonathan Bruce Barber; Stephen J Gibson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Oxaprozin pharmacokinetics in the elderly.

Authors:  D J Greenblatt; R Matlis; J M Scavone; G T Blyden; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

10.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.